Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Luliconazole in pediatric tinea corporis
NCT02767947Phase 4Completed
- Sponsor
- Valeant Pharmaceuticals
- Start
- Feb 2016
- Primary completion
- Jun 2016
- Countries
- 2
01
Overview
Phase 4, randomised, double-blind trial of luliconazole vehicle cream in tinea corporis (2 arms), sponsored by Valeant Pharmaceuticals. Primary endpoints: Circulating Plasma Concentration of Luliconazole at Day 7 (Pre-Dose) and Circulating Plasma Concentration of Luliconazole at Day 7 (6 Hours Post-Dose). Started Feb 2016; status: completed.
02
Drugs
luliconazole vehicle cream
03
Conditions
tinea corporis
Beyond the preview
Go deeper on NCT02767947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02767947.